文献速递骨肿瘤关节外科运动医学

髋膝关节肿瘤假体患者躯体功能与生活质量的临床重要下降:横断面研究

Clinically Important Reductions in Physical Function and Quality of Life in Adults with Tumor Prostheses in the Hip and Knee: A Cross-sectional Study.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

该横断面研究纳入30例髋膝骨肿瘤假体置换术后2-12年患者及30名年龄性别匹配对照,发现患者手术侧和非手术侧伸膝及髋外翻肌力均显著降低,疼痛常见,6分钟步行和30秒坐立试验能力及TESS评分均较差,且肌力与疼痛和EORTC QLQ-C30躯体功能相关。

要点

  • 髋膝肿瘤假体患者手术侧与非手术侧伸膝和髋外翻肌力均显著低于对照。
  • 疼痛较高和肌力较低与EORTC QLQ-C30躯体功能评分较低相关。

核心结论

  • 髋膝肿瘤假体患者存在临床重要的肌力下降,不仅累及切除侧肌肉,也累及对侧肢体。
  • 许多患者报告疼痛,其步行和坐立能力下降程度与老年人相当。
  • 结果可用于术前信息告知,术后监测建议评估客观躯体功能。

研究设计与样本

  • 横断面研究,纳入2006至2016年因骨肉瘤或骨巨细胞瘤行髋或膝肿瘤假体置换的患者30例,对照30名按性别和年龄(±4岁)匹配。
  • 患者评估时间为切除重建术后2至12年(平均7±3年),平均年龄51±18岁,对照平均年龄52±17岁。
  • 评估内容包括被动ROM、手持测力计等长肌力、疼痛NRS和分布图、6分钟步行试验、30秒坐立试验、TESS和EORTC QLQ-C30。

主要发现

  • 伸膝肌力患者手术侧0.9±0.5 Nm/kg vs 对照2.1±0.6 Nm/kg(均差-1.3 Nm/kg [95%CI -1.5至-1.0];p<0.001),非手术侧1.7±0.6 vs 2.2±0.6 Nm/kg(均差-0.5 [95%CI -0.8至-0.2];p=0.003)。
  • 髋外翻肌力患者手术侧1.1±0.4 Nm/kg vs 对照1.9±0.5 Nm/kg(均差-0.7 [95%CI -1.0至-0.5];p<0.001),非手术侧1.5±0.4 vs 1.9±0.5 Nm/kg(均差-0.4 [95%CI -0.6至-0.2];p=0.001)。
  • 近端股骨重建患者髋屈曲ROM为113°±18° vs 对照130°±11°(均差-17°;p=0.006);远端股骨重建患者膝屈曲ROM为113°±29° vs 对照146°±9°(均差-34°;p=0.002)。
  • 6分钟步行距离患者499±100米 vs 对照607±68米(均差-108米;p<0.001);30秒坐立试验12±5次 vs 18±5次(均差-7次;p<0.001);TESS中位数78(IQR 21)分 vs 100(IQR 10)分(p<0.001)。

关键数值与推荐

  • 肌力最小临床重要差异为20%至25%,NRS为2分,6分钟步行试验为14至31米,30秒坐立试验为2次,TESS为12至15分,EORTC QLQ-C30为5至20分。
  • TESS和EORTC QLQ-C30归一化为0至100分,TESS和EORTC总体健康及躯体功能量表评分越高表示状态越好。

临床怎么用

  • 术前可依据这些客观躯体功能数据向患者提供预期信息。
  • 术后监测建议评估客观躯体功能,包括肌力、步行能力和坐立能力。
  • 需关注患者疼痛及对侧肢体肌力下降,并据此设计针对性康复干预。

局限性

  • 横断面设计无法评估躯体功能随时间的变化轨迹。
  • 样本量较小,仅30例患者和30名对照,且部分患者因年龄、妊娠、交通、姑息治疗或拒绝参与而被排除。
  • 证据等级为Level III,治疗性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with a bone sarcoma who undergo limb-sparing surgery and reconstruction with a tumor prosthesis in the lower extremity have been shown to have reduced self-reported physical function and quality of life (QoL). To provide patients facing these operations with better expectations of future physical function and to better evaluate and improve upon postoperative interventions, data from objectively measured physical function have been suggested. QUESTIONS/PURPOSES: We sought to explore different aspects of physical function, using the International Classification of Functioning, Disability, and Health (ICF) as a framework, by asking: (1) What are the differences between patients 2 to 12 years after a bone resection and reconstruction surgery of the hip and knee following resection of a bone sarcoma or giant cell tumor of bone and age-matched controls without walking limitations in ICF body functions (ROM, muscle strength, pain), ICF activity and participation (walking, getting up from a chair, daily tasks), and QoL? (2) Within the patient group, do ICF body functions and ICF activity and participation outcome scores correlate with QoL? METHODS: Between 2006 and 2016, we treated 72 patients for bone sarcoma or giant cell tumor of bone resulting in bone resection and reconstruction with a tumor prosthesis of the hip or knee. At the timepoint for inclusion, 47 patients were alive. Of those, 6% (3 of 47) had undergone amputation in the lower limb and were excluded. A further 32% (14 of 44) were excluded because of being younger than 18 years of age, pregnant, having long transportation, palliative care, or declining participation, leaving 68% (30 of 44) for analysis. Thus, 30 patients and 30 controls with a mean age of 51 ± 18 years and 52 ± 17 years, respectively, were included in this cross-sectional study. Included patients had been treated with either a proximal femoral (40% [12 of 30]), distal femoral (47% [14 of 30]), or proximal tibia (13% [4 of 30]) reconstruction. The patients were assessed 2 to 12 years (mean 7 ± 3 years) after the resection-reconstruction. The controls were matched on gender and age (± 4 years) and included if they considered their walking capacity to be normal and had no pain in the lower extremity. Included outcome measures were: passive ROM of hip flexion, extension, and abduction and knee flexion and extension; isometric muscle strength of knee flexion, knee extension and hip abduction using a hand-held dynamometer; pain intensity (numeric rating scale; NRS) and distribution (pain drawing); the 6-minute walk test (6MWT); the 30-second chair-stand test (CST); the Toronto Extremity Salvage Score (TESS), and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). The TESS and the EORTC QLQ-C30 were normalized to 0 to 100 points. Higher scoring represents better status for TESS and EORTC global health and physical functioning scales. Minimum clinically important difference for muscle strength is 20% to 25%, NRS 2 points, 6MWT 14 to 31 meters, CST 2 repetitions, TESS 12 to 15 points, and EORTC QLQ-C30 5 to 20 points. RESULTS: Compared with controls, the patients had less knee extension and hip abduction strength in both the surgical and nonsurgical limbs and regardless of reconstruction site. Mean knee extension strength in patients versus controls were: surgical limb 0.9 ± 0.5 Nm/kg versus 2.1 ± 0.6 Nm/kg (mean difference -1.3 Nm/kg [95% CI -1.5 to -1.0]; p < 0.001) and nonsurgical limb 1.7 ± 0.6 Nm/kg versus 2.2 ± 0.6 Nm/kg (mean difference -0.5 Nm/kg [95% CI -0.8 to -0.2]; p = 0.003). Mean hip abduction strength in patients versus controls were: surgical limb 1.1 ± 0.4 Nm/kg versus 1.9 ± 0.5 Nm/kg (mean difference -0.7 Nm/kg [95% CI -1.0 to -0.5]; p < 0.001) and nonsurgical limb 1.5 ± 0.4 Nm/kg versus 1.9 ± 0.5 Nm/kg (-0.4 Nm/kg [95% CI -0.6 to -0.2]; p = 0.001). Mean hip flexion ROM in patients with proximal femoral reconstructions was 113° ± 18° compared with controls 130° ± 11° (mean difference -17°; p = 0.006). Mean knee flexion ROM in patients with distal femoral reconstructions was 113° ± 29° compared with patients in the control group 146° ± 9° (mean difference -34°; p = 0.002). Eighty-seven percent (26 of 30) of the patients reported pain, predominantly in the knee, anterior thigh, and gluteal area. The patients showed poorer walking and chair-stand capacity and had lower TESS scores than patients in the control group. Mean 6MWT was 499 ± 100 meters versus 607 ± 68 meters (mean difference -108 meters; p < 0.001), mean CST was 12 ± 5 repetitions versus 18 ± 5 repetitions (mean difference -7 repetitions; p < 0.001), and median (interquartile range) TESS score was 78 (21) points versus 100 (10) points (p < 0.001) in patients and controls, respectively. Higher pain scores correlated to lower physical functioning of the EORTC QLQ-C30 (Rho -0.40 to -0.54; all p values < 0.05). Less muscle strength in knee extension, knee flexion, and hip abduction correlated to lower physical functioning of the EORTC QLQ-C30 (Rho 0.40 to 0.51; all p values < 0.05). CONCLUSION: This patient group demonstrated clinically important muscle weaknesses not only in resected muscles but also in the contralateral limb. Many patients reported pain, and they showed reductions in walking and chair-stand capacity comparable to elderly people. The results are relevant for information before surgery, and assessments of objective physical function are advisable in postoperative monitoring. Prospective studies evaluating the course of physical function and which include assessments of objectively measured physical function are warranted. Studies following this patient group with repetitive measures over about 5 years could provide information about the course of physical function, enable comparisons with population norms, and lead to better-designed, targeted, and timely postoperative interventions. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Fernandes L, Holm CE, Villadsen A, et al. Clinically Important Reductions in Physical Function and Quality of Life in Adults with Tumor Prostheses in the Hip and Knee: A Cross-sectional Study. Clin Orthop Relat Res. 2021. PMID: 33974591. doi:10.1097/CORR.0000000000001797

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。